Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer

ConditionLung Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversity of California, Davis

About this trial

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.

Eligibility criteria

Qualifiers

Histologically or cytologically confirmed lung cancer

Not specified

May have received prior EGFR inhibitors

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

800 Participants

are grouped into 1 trial group

Sponsors and collaborators

University of California, Davis

Lead sponsor

Source ClinicalTrials.gov